India Why Is Biocon’s Itolizumab Trial Deeply Flawed? | The Wire Science | COVID-19 Updates Team Buyback 6 September 2020, 8:56 pm6 September 2020, 8:56 pm India, The Wire Share this:TweetRedditTelegramWhatsApp